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http://dxObjectives: A systematic review of the European System for Cardiac Operative Risk Evaluation (euroSCORE)
II performance for prediction of operative mortality after cardiac surgery has not been performed. We conducted
a meta-analysis of studies based on the predictive accuracy of the euroSCORE II.
Methods:We searched the Embase and PubMed databases for all English-only articles reporting performance
characteristics of the euroSCORE II. The area under the receiver operating characteristic curve, the observed/
expected mortality ratio, and observed-expected mortality difference with their 95% confidence intervals were
analyzed.
Results: Twenty-two articles were selected, including 145,592 procedures. Operative mortality occurred in
4293 (2.95%), whereas the expected events according to euroSCORE II were 4802 (3.30%). Meta-analysis
of these studies provided an area under the receiver operating characteristic curve of 0.792 (95% confidence
interval, 0.773-0.811), an estimated observed/expected ratio of 1.019 (95% confidence interval, 0.899-
1.139), and observed-expected difference of 0.125 (95% confidence interval, 0.269 to 0.519). Statistical het-
erogeneity was detected among retrospective studies including less recent procedures. Subgroups analysis
confirmed the robustness of combined estimates for isolated valve procedures and those combined with revas-
cularization surgery. A significant overestimation of the euroSCORE II with an observed/expected ratio of 0.829
(95% confidence interval, 0.677-0.982) was observed in isolated coronary artery bypass grafting and a slight
underestimation of predictions in high-risk patients (observed/expected ratio 1.253 and observed-expected dif-
ference 1.859).
Conclusions:Despite the heterogeneity, the results from this meta-analysis show a good overall performance of
the euroSCORE II in terms of discrimination and accuracy of model predictions for operative mortality. Vali-
dation of the euroSCORE II in prospective populations needs to be further studied for a continuous improvement
of patients’ risk stratification before cardiac surgery. (J Thorac Cardiovasc Surg 2014;148:3049-57)A
C
DSupplemental material is available online.
Predictive models are used to generate a risk of event
according to the patient risk factor profile. In cardiac
surgery, the focus has been to identify available and
measurable risk factors that best predict the mortality.
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The Journal of Thoracic and CarEvaluation (euroSCORE) group has developed multivari-
able models for quantifying the impact of multiple risk
factors on cardiac surgery operative mortality.1-3 The
initial score system was recently updated with new data
used to generate the model named ‘‘euroSCORE II.’’3
The new system, published in February 2012, showed
higher discrimination and better calibration than the previ-
ous model.3 To date, the performance of the euroSCORE
II has been assessed in several studies. However, general-
ization of results assessing the external performance of the
euroSCORE II is limited by differences between popula-
tions that may influence the predictive accuracy of a
scoring system applied to local circumstances. An appro-
priate systematic evaluation of the euroSCORE II should
include all evidence and results of available individual
studies. We performed a meta-analysis (1) to assess euro-
SCORE II discriminatory power estimated by the area un-
der the curve (AUC) receiver operating characteristic
(ROC) and (2) to compare observed versus euroSCORE
II predicted mortality.diovascular Surgery c Volume 148, Number 6 3049
FIGURE 1. Flow diagram showing the process of study selection.
Abbreviations and Acronyms
AUC ¼ area under the curve
CABG ¼ coronary artery bypass grafting
CI ¼ confidence interval
euroSCORE ¼ European System for Cardiac
Operative Risk Evaluation
O/E ¼ observed/expected
O-E ¼ observed-expected
ROC ¼ receiver operating characteristic
STS ¼ Society of Thoracic Surgeons
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Literature Search
A systematic review of published evidence on the performance value of
the euroSCORE II was undertaken using published guidelines for meta-
analysis of observational studies.4 On February 26, 2014, one investigator
(FM) searched Embase and PubMed sources for all articles reporting per-
formance characteristics of the euroSCORE II. The free-text ‘‘euroSCORE
II’’ was used as search term for finding the articles published after January
2012.Moreover, we evaluated bibliographies of retrieved studies and all ar-
ticles citing the original euroSCORE II study obtained from the European
Journal of Cardio-Thoracic Surgery website.
Study Selection
The inclusion criteria were as follows: full-text English-only articles
evaluating predictive performance of the euroSCORE II on perioperative
mortality in cardiac surgery. Two co-authors (FM and PG) independently
reviewed each abstract. According to a standardized data-extraction
form, they read all the abstracts to identify the potentially eligible articles
and then used the full text of these articles to determine whether they could
be included. Discordant opinions were resolved by discussion with the
participation of a third investigator (DP). Duplicate publications were
excluded. In the circumstance that multiple articles reported on the same
dataset, the published article with the greatest number of patients was
selected. Articles with very specific domains were excluded (ie, endocardi-
tis or aortic dissection).
Parameters Extracted
The number of patients, their mean age, and the proportion of female
gender were extracted. The following parameters were considered: mortal-
ity, the AUC of the ROC, and the euroSCORE II mean value. We attempted
to obtainmissing data from the authors by electronicmail to addresses cited
in articles. The periods of enrollment, number of centers, types of surgeries
performed, and definition of mortality were reported for each study.
Statistical Analysis
We calculated the observed mortality according to the number of events
reported in the original studies. To standardize the estimation of the 95%
confidence interval (CI) among studies, the mortality rate was estimated by
using the normal approximation of binomial distribution and the 95% CI of
AUC was estimated using an approximate formula.5 The mortality
observed/expected (O/E) ratio and observed-expected (O-E) were calculated
for each study. A value of O/E greater than 1 means that the euroSCORE II
model underestimated relative mortality, whereas a value less than 1 means
that the model overestimated mortality. If the 95% CI of the O/E ratio
excluded the value 1.0, it was considered statistically significant. A value of
O-E greater than 0 means that the euroSCORE II model underestimated
absolute mortality, whereas a value less than 0 means that the model3050 The Journal of Thoracic and Cardiovascular Suroverestimated mortality. If the 95% CI of the O-E difference excluded the
value 0, it was considered statistically significant. Parameters analyzed
were the AUC of the ROC, O/E ratio, and O-E difference with their 95%
CI. The forest plot of AUC, O/E ratio, and O-E difference with their 95%
CIs were displayed. Heterogeneity among studies was evaluated by the
chi-square test (P<.05). Baujat plot was used as a graphic method to identify
studies that affect heterogeneity or themeta-analytic estimate.6We conducted
a meta-regression analysis based on study-level data: Mean age, number of
centers involved (multicenter vs single-center study), proportion of isolated
coronary artery bypass grafting (CABG), presence of patients operated before
euroSCORE II study population, and mortality definition (in-hospital vs
30 days) were considered as explanatory variables. The random-effects
approachwas used to account for unexplained heterogeneity between studies.
To evaluate the predictive accuracy of euroSCOREII according to the number
of centers involved in each study, a sensitivity of thefindingswas examined by
separately performing the analysis with multicenter and single-center
studies. Subgroups analysis was focused on isolated CABG, isolated valve
surgery, and combined procedures (CABG with valve surgery). Moreover,
high-risk surgery was evaluated by extracting procedures with greater
preoperative score or nonelective surgery. The analyses were made using
STATA software, version 12 (StataCorp LP, College Station, Tex).
RESULTS
Literature Search
Figure 1 presents the flow diagram of study selection. A
total of 135 and 374 citations were retrieved from PubMed
and Embase databases, respectively. Among all these arti-
cles, 31 studies were considered for more detailed evalua-
tion. Inclusion and exclusion criteria were fulfilled by 24
studies that were selected for data extraction and analysis;
22 studies were included in the main analysis,3,7-27 and 2
studies were included only for subgroup analysis28,29
because they reported on surgery categories extracted
from datasets of other included articles.10,23
Characteristics of the Studies Included in the Meta-
Analysis
Table 1 shows the principal characteristics of the studies
included in the meta-analysis.3,7-29 The number of
participants who were assessed in the studies ranged fromgery c December 2014
TABLE 1. Main characteristics of the studies included in the meta-analysis
Study (reference)
Enrollment
(y)
Centers
(n)
Patients
(n)
Age
(y)
Female
(%)
Mortality
(%)
euroSCORE II
(%) AUC Surgery
Nashef and colleagues3 2010 154 5553 64.6 30.9 4.2 4.0 0.81 Cardiac surgery
Biancari and colleagues7 2006-2011 1 1027 67.0 22.2 2.7 4.5 0.87 Isolated CABG
Di Dedda and colleagues8 2010-2011 1 1090 64.5 31.7 3.8* 3.1 0.81 Cardiac surgery
Chalmers and colleagues9 2006-2010 1 5576 69.3 28.6 3.4 4.5 0.79 Cardiac surgery
Grant and colleagues10 2010-2011 41 23,740 67.1 27.7 3.1 3.4 0.81 Cardiac surgery
Carnero-Alcazar and colleagues11 2005-2010 1 3798 67.0 37.7 5.7y 4.5 0.85 Cardiac surgery
Kunt and colleagues12 2004-2012 1 428 74.5 35.0 7.9 1.7 0.72 Isolated CABG
Kirmani and colleagues13 2001-2010 1 15,497 65.3 27.6 3.5 2.5 0.82 Cardiac surgery
Howell and colleagues14 2006-2011 2 933 74.3 42.6 9.7 11.3 0.67 High-risk surgery
Wang and colleagues15 2008-2011 4 11,170 49.0 53.1 2.0 2.6 0.72 Valve surgery
Borde and colleagues16 2011-2012 1 498 60.5 19.9 1.6 2.0 0.69 Cardiac surgery
Qadir and colleagues17 2006-2010 1 2004 58.3 17.3 3.8y 3.7 0.84 Isolated CABG
Spiliopoulos and colleagues18 1999-2005 1 216 66.2 27.3 6.5y 4.0 0.77 AVR and CABG
Wendt and colleagues19 1999-2012 1 1066 68.3 46.2 4.2* 3.2 0.724 Isolated AVR
Laurent and colleagues20 2009-2011 1 314 73.4 41.1 5.7* 2.3 0.77 AVR
Wang and colleagues21 2010-2012 1 818 64.5 20.5 1.6y 2.6 0.64 Isolated CABG
Nishida and colleagues22 1993-2013 1 461 63.5 35.4 7.2 7.4 0.77 Thoracic aorta surgery
Barili and colleagues23 2006-2012 3 12,201 67.3 32.1 1.7 2.5 0.80 Elective surgery
Barili and colleagues23 2006-2012 3 1670 68.1 26.4 7.5 6.2 0.82 Nonelective surgery
Paparella and colleagues24 2011-2012 7 6191 67.4 34.1 4.8 4.4 0.83 Cardiac surgery
Carosella and colleagues25 2008-2012 4 250 68.6 36.8 3.6 1.6 0.76 AVR
Borracci and colleagues26 2012-2013 >1 503 66.4 25.2 4.2 3.2 0.86 Cardiac surgery
Osnabrugge and colleagues27 2003-2012 17 50,588 64.7 28.9 2.1 3.1 0.77 Cardiac surgery
Other subcategories
Di Dedda and colleagues8 2010-2011 1 372 — — 2.1* 1.9 0.70 Isolated CABG
Di Dedda and colleagues8 2010-2011 1 206 — — 1.9* 2.1 0.79 Isolated AVR
Di Dedda and colleagues8 2010-2011 1 200 — — 4.5* 3.8 0.89 Isolated mitral surgery
Chalmers and colleagues9 2006-2010 1 2913 67.9 18.2 1.9 3.0 0.79 Isolated CABG
Chalmers and colleagues9 2006-2010 1 814 70.7 44.4 2.3 3.7 0.69 Isolated AVR
Chalmers and colleagues9 2006-2010 1 340 66.7 45.0 1.5 3.8 0.87 Isolated mitral surgery
Grant and colleagues10 2010-2011 41 12,470 — — 1.5 2.1 0.80 Isolated CABG
Grant and colleagues10 2010-2011 41 3116 — — 2.1 2.6 0.77 Isolated AVR
Grant and colleagues10 2010-2011 41 2401 — — 4.4 4.8 0.72 AVR and CABG
Carnero-Alcazar and
colleagues11
2005-2010 1 1231 — — 3.1y 3.3 0.90 Isolated CABG
Carnero-Alcazar and
colleagues11
2005-2010 1 1727 — — 6.1y 4.4 0.83 Isolated valve surgery
Carnero-Alcazar and
colleagues11
2005-2010 1 301 — — 8.0y 5.8 0.77 Valve and CABG
Kunt and colleagues12 2004-2012 1 142 — — 16.9 2.8 — High-risk isolated CABG
Kirmani and colleagues13 2001-2010 1 3083 — — 10.9 7.1 — High-risk cardiac surgery
Qadir and colleagues17 2006-2010 1 76 — — 9.2y 11.8 — High-risk isolated CABG
Laurent and colleagues20 2009-2011 1 64 — — 17.2 5.2 — High-risk AVR
Paparella and colleagues24 2011-2012 7 2605 68.1 20.9 3.0 2.7 0.83 Isolated CABG
Paparella and colleagues24 2011-2012 7 1283 68.8 46.9 2.7 2.7 0.78 Isolated valve surgery
Paparella and colleagues24 2011-2012 7 502 71.6 35.3 7.8 6.3 0.79 Valve and CABG
Paparella and colleagues24 2011-2012 7 1201 67.6 28.1 12.2 8.5 0.82 Nonelective surgery
Carosella and colleagues25 2008-2012 4 89 — — 9.0 2.7 — High-risk AVR
Borracci and colleagues26 2012-2013 >1 273 — — 2.2 1.5 0.79 Isolated CABG
Osnabrugge and colleagues27 2003-2012 17 40,871 — — 1.8 2.9 0.77 Isolated CABG
Osnabrugge and colleagues27 2003-2012 17 4107 — — 2.9 3.0 0.71 Isolated AVR
Osnabrugge and colleagues27 2003-2012 17 1059 — — 1.3 2.1 0.82 Isolated MV repair
Osnabrugge and colleagues27 2003-2012 17 1071 — — 5.6 4.6 0.78 Isolated MV replacement
Osnabrugge and colleagues27 2003-2012 17 3480 — — 4.1 5.4 0.72 AVR and CABG
(Continued)
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TABLE 1. Continued
Study (reference)
Enrollment
(y)
Centers
(n)
Patients
(n)
Age
(y)
Female
(%)
Mortality
(%)
euroSCORE II
(%) AUC Surgery
Osnabrugge and colleagues27 2003-2012 17 213 — — 11.3 21.9 — High-risk AVR
Grant and colleagues28 2010-2011 41 762 62.5 31.8 16.0 15.6 0.69 Emergency surgery
Barili and colleagues29 2006-2012 3 1758 69.8 45.0 1.4 1.9 0.81 Isolated AVR
AUC, Area under the curve; AVR, aortic valve replacement; CABG, coronary artery bypass grafting; euroSCORE, European System for Cardiac Operative Risk Evaluation;MV,
mitral valve. *Thirty-day mortality. yIn-hospital or 30-day mortality. Validation cohort was considered for the original euroSCORE II article by Nashef and colleagues.3 Further
data in addition to those provided in the original article were provided by Paparella and colleagues.24 euroSCORE II values were extracted by graphs in the study by Chalmers and
colleagues9 and Howell and colleagues14 or provided by mail for Wang and colleagues.21 High-risk surgery was defined as logistic euroSCORE10 by Howell and colleagues,14
the highest tertile for Kunt and colleagues12 and Carosella and colleagues,25 the highest quintile for Qadir and colleagues17 and Laurent and colleagues,20 and predicted risk of
mortality>10% by Osnabrugge and colleagues.27 The 2 highest deciles were extracted for Kirmani and colleagues.13
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D216 to 50,588.3,7-27 Among the 145,592 patients (weighted
mean age, 64.6 years; 31.2%were female), there were 4293
(2.95%) observed deaths and 4802 (3.30%) expected
deaths. Fifteen studies reported in-hospital mortality as
the main outcome. Of the 136,286 patients in these studies,
3871 (2.84%) died before the discharge and 4453 (3.27%)
deaths were expected.Discrimination and Predictive Accuracy
Figure 2 shows the forest plot of the AUC of the ROC,
O/E ratio, and O-E difference for the studies included in
the main analysis.3,7-27 Statistical heterogeneity was
detected across studies. As a whole, our data demonstrate
that the euroSCORE II has good overall ability to
differentiate between patients who died and survived with
an AUC of 0.792 (95% CI, 0.773-0.811). The accuracy of
predictions was estimated with an O/E ratio of 1.019
(95% CI, 0.899-1.139) and O-E difference of 0.125 (95%
CI, 0.269 to 0.519). The overall discrimination and
predictive accuracy of euroSCORE II were similar
between studies that evaluated hospital mortality by
including only patients operated after the euroSCORE II
cohort and those that evaluated 30-daymortality or included
patients with a completely retrospective evaluation of the
euroSCORE II: AUC 0.814 (95% CI, 0.800-0.828) versus
0.783 (95% CI, 0.759-0.807), O/E ratio 1.020 (95% CI,
0.908-1.133) versus 1.030 (95% CI, 0.878-1.181), and
O-E difference 0.074 (95% CI, 0.331 to 0.479) versus
0.163 (95%CI,0.333 to 0.659). Figure E1 shows a Baujat
plot to evaluate the impact of studies on heterogeneity and
on the meta-analytic estimate. As displayed in Figure E1, A,
2 studies with low AUC contributed to the variability and
overall estimate,14,15 and the study with the highest
discrimination affected heterogeneity.11 The largest study
involved in this meta-analysis had an impact on heterogene-
ity, and another wide study deviated from the overall
estimate because of underestimation of the predicted risk
(Figure E1, B and C). Both studies were large retrospective
evaluations of patients undergoing operation over a 10-year
period.13,27 Studies that evaluated hospital mortality by
including only the most recent patients operated after the3052 The Journal of Thoracic and Cardiovascular SureuroSCORE II cohort had a low impact on both
heterogeneity and overall result (Figure E1, group B).Sensitivity Analysis
When the 9 multicenter studies (112,799 patients)
were analyzed,3,10,14,15,23-27 the discrimination remained
preserved with an AUC of 0.786 (95% CI, 0.760-0.812)
without deviation between observed and expected
mortality: The O/E ratio was 0.925 (95% CI,
0.797-1.053), and O-E difference was 0.215 (95% CI,
0.602 to 0.172). The analysis of the 13 single-center
studies7-9,11-13,16-22 estimated an AUC of 0.801 (95% CI,
0.775-0.827), an O/E ratio of 1.146 (95% CI, 0.915-
1.377), and an O-E difference of 0.517 (95% CI, 0.254
to 1.289).Meta-Regression Analysis
Multiple regression analysis (Table 2) did not show a sig-
nificant association between the euroSCORE II perfor-
mance parameters (AUC ROC, O/E ratio, or O-E
difference) and the study-specific data (mean age, multi-
center vs single-center category, presence of patients oper-
ated before 2010, proportion of isolated CABG, and
definition of mortality used).Subgroup Analysis
Figure 3 shows the forest plot of AUC, O/E ratio, and O-E
difference for isolated CABG,7-12,17,21,24,26,27 isolated valve
surgery,8-11,19,24,27,29 and combined CABG and valve
procedures.10,11,18,24,27 Statistical heterogeneity was
detected across studies for O/E ratio and O-E difference
(P< .01 in each subgroup and overall). The euroSCORE
II showed overall good discrimination in isolated CABG
(AUC, 0.804; 95% CI, 0.771-0.837) and valve surgery
(AUC, 0.777; 95% CI, 0.744-0.811). A lower AUC was
observed in combined procedures (0.735; 95% CI, 0.704-
0.767). The agreement between observed and expected
mortality was good for isolated valve procedures: O/E
ratio 0.925 (95% CI, 0.753-1.096) and O/E difference
0.193 (95% CI, 0.681 to 0.296). No deviation
between estimated mortality and predicted risk wasgery c December 2014
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The Journal of Thoracic and Carobserved in the combined surgery group: O/E ratio 1.030
(95% CI, 0.798-1.262) and O/E difference 0.176 (95%
CI, 1.041 to 1.393). An overestimation of the
euroSCORE II was observed for isolated CABG surgery:
O/E ratio 0.829 (95% CI, 0.677-0.982) and O/E
difference 0.397 (95% CI, 0.846 to 0.051).High-Risk Procedures
When nonelective surgery or patients at greater preoper-
ative risk were analyzed as high risk,12-14,17,20,23-25,27,28 the
euroSCORE II had a lower discrimination estimated by an
AUC of 0.752 (95% CI, 0.676-0.828) and a nonsignificant
underestimation of prediction: O/E ratio 1.253 (95% CI,
0.936-1.570) and O/E difference 1.859 (95% CI, 0.615
to 4.332).A
C
DDISCUSSION
Predictionmodels play an important role in current cardiac
surgical practice, and the euroSCORE II is one of the several
available tools to assess the risk of perioperative mortality.
Among the numerous models that have been developed for
risk stratification, the euroSCORE II is the most recent risk
assessment system developed using widely available clinical
variables and operation-related factors.3 The score is an
update of the old logistic euroSCORE model and is derived
from amore contemporary data set that better reflects current
cardiac surgical practice. We undertook a meta-analysis of
euroSCOREII overall performance byassessing the available
literature and combining results from different populations
to obtain summary estimates with greater precision and
statistical power than individual studies.
There has been recent interest in developing a more
robust and objective scoring system to cover a wider popu-
lation of cardiac surgical patients.30-32 The most frequently
used risk calculators are the Society of Thoracic Surgeons
(STS) Risk Score in North America and the euroSCORE
in Europe. The STS Risk Score was most updated in 2008
from a large multicenter database in the United States.
The STS Risk Tool was derived separately for CABG,
valve procedures, and combined CABG with valve
surgery to predict mortality and morbidity.30-32 In
comparison with the STS Risk Score, the euroSCORE II
was developed over a lower number of patients involvedFIGURE 2. Forest plot of studies estimating the AUC ROC (A), O/E ratio
(B) and O-E difference (C). Group A included studies with a retrospective
evaluation of the euroSCORE II or that evaluated 30-day mortality as the
main outcome. Group B included studies that evaluated hospital mortality
by including only patients undergoing operation after the euroSCORE II
cohort. The first author and reference as shown in Table 1. ROC, Receiver
operating characteristic.
diovascular Surgery c Volume 148, Number 6 3053
TABLE 2. Meta-regression analysis
AUC ROC Observed/expected ratio Observed-expected difference
Coefficient P value Coefficient P value Coefficient P value
Mean age (y) 0.000 .984 0.023 .280 0.092 .172
Multicenter study 0.018 .617 0.113 .692 0.212 .817
Presence of patients operated before 2010 0.027 .360 0.044 .853 0.233 .755
Proportion of isolated CABG 0.001 .986 0.210 .527 0.359 .722
In-hospital mortality as main outcome 0.003 .945 0.209 .494 0.722 .448
AUC, Area under the curve; CABG, coronary artery bypass grafting; ROC, receiver operating characteristic.
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Din the derivation cohort and included less variables
and interaction terms between risk factors for the
prediction of early mortality after different types of
cardiac surgery.3,30-32 The euroSCORE II was derived
from a database of more than 20,000 consecutive patients
from 154 hospitals in 43 countries who underwent
operation from May to July 2010. Information on risk
factors was collected and compared by patients’ outcomes
in terms of hospital mortality. By means of logistic
regression analysis, those risk factors that were robust in
predicting mortality became part of the euroSCORE II
calculation.3 Several authors have evaluated the external
validity of the euroSCORE II to test the generalizability
of this prediction model.7-29,33,34 We conducted a meta-
analysis to evaluate the discrimination of predictions and
the agreement with mortality. By combining results from
different studies, our meta-analysis of these studies shows
that the euroSCORE II had good ability in distinguishing
patients who survived from those who died after the surgery
with an accurate risk estimation. Discrimination was
confirmed for isolated valve surgery and CABG. The euro-
SCORE II overestimated the risk with a significant O/E
ratio in isolated CABG. We observed an underestimation
of the predictions in high-risk procedures. There was
evidence of substantial heterogeneity between studies for
parameters of discrimination and model predictive
accuracy. At meta-regression analysis, study-level data
considered as explanatory variables of euroSCORE II per-
formance were not significant. However, subgroup analysis
showed that the studies that evaluated 30-day mortality or
included patients with a completely retrospective evalua-
tion of euroSCORE II had a great impact on variability of
the estimated measures. When hospital mortality was
evaluated by including more recent procedures (patients
operated after the euroSCORE II cohort), heterogeneity
was not significant or less evident. We addressed the issue
of heterogeneity between studies by computing pooled esti-
mates from a random-effects model. Our data, despite the
score performance differing across studies, confirmed the
global validity of the euroSCORE II as a tool for patient
selection. Part of the variability detected among studies
may be due to differences in performance between centers3054 The Journal of Thoracic and Cardiovascular Suror surgeons. D’Errigo and colleagues35 evaluated the
amount of differences in adjusted mortality rates (30-day
mortality after CABG) due to differences between centers
with a significant proportion of variability explained by
different performance among cardiac surgery centers. Kilic
and colleagues36 considered the combined effect of volume
of procedures performed for operative outcomes in mitral
valve surgery: Both surgeon and hospital volume correlated
significantly with operative mortality, and lower surgeon
volume persisted as a significant risk factor in the risk-
adjusted analysis. Papachristofi and colleagues37 evaluated
the impact of surgeons on outcome after cardiac surgery.
They showed that in-hospital death, in a large cohort of
cardiac surgical patients, was determined primarily by the
patient risk profile and by a small but significant difference
in outcome between surgeons. The number and range of
participating units included in the development of the euro-
SCORE II were greater than those involved in the validation
studies7-29 and fairly representative of current cardiac
surgery to obtain a robust cardiac surgery risk model.3
Moreover, a small evidence of inter-hospital heterogeneity
was detected in the euroSCORE II original cohort.3
The performance of the recently updated euroSCORE II
has been assessed in several studies.7-29 Most of the
analyzed populations were retrospective or prospective for
only the most recent cases. Large prospective national and
regional multicenter registries including contemporary
patients undergoing cardiac surgery have confirmed the
good performance of the euroSCORE II as a generic
model for all cardiac surgery.10,24 Grant and colleagues10
conducted the largest prospective study assessing the per-
formance of the euroSCORE II in UK cardiac surgery
analyzing the multicenter data from the Society for Cardio-
thoracic Surgery in Great Britain and Ireland Database that
included 23,740 procedures between July 2010 and March
2011 from all National Health Service hospitals and some
UK private centers. The euroSCORE II performed well
with a poor calibration for isolated CABG surgery and in
both the highest and lowest risk patients.10 A significant
overprediction of mortality for isolated CABG was
observed in the largest study included in our meta-
analysis. The analysis of data from a consortium of 17gery c December 2014
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The Journal of Thoracic and Carcardiac surgical centers providing cardiac surgery in the
Commonwealth of Virginia (50,588 procedures with
40,871 isolated CABGs performed between 2003 and
2012) showed a large deviation between observed and pre-
dicted mortality.27 This study had a great impact on hetero-
geneity and overall estimation. By excluding this study
from the meta-analysis, the euroSCORE II showed a good
accuracy for isolated CABG (O/E ratio not significant)
with a significant underestimation in high-risk procedures
(data not shown). Compared with the performance in all
cardiac surgery, the euroSCORE II showed poorer discrim-
ination and lower calibration for nonelective and high-risk
surgery. The poor performance of the euroSCORE II in
emergency procedures was demonstrated in both prospec-
tive registries that validated the model.10,24 No risk model
is perfect, nor do all risk factors appear in all models. It is
possible that concomitant risk factors not incorporated in
the euroSCORE II and the variation in outcomes between
centers or surgeons may reduce the accuracy of predicted
events mainly in patients at higher risk.
One of the possible purposes of the cardiac risk score is to
help assess the quality of cardiac surgical care, the so-called
benchmarking, by comparing observed mortality rates
with the expected rates. A risk model constructed for bench-
marking should be accurate in all risk groups, so that fair
comparisons between providers can be made.38 The validity
of euroSCORE II for benchmarking of healthcare providers
should be better evaluated.A
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DStudy Limitations
Only studies published in English were selected. There is
the possibility of publication bias because studies obtaining
favorable results could be published more easily than
studies with unfavorable results in terms of mortality
compared with predicted risk. Studies that included patients
before the actual introduction of the euroSCORE II may be
less accurate because the risk score was retrospectively
computed, and dynamic changes could be present in the pa-
tient characteristics, case-mix, and baseline risk relative of
patients who underwent surgery over a wide study period
before the development of the euroSCORE II. We evaluated
the overall agreement between predicted and observed fre-
quencies in each study comparing mortality with expected
risk. Wewere not able to evaluate calibration within subcat-
egory of risk for lack of data.FIGURE 3. Forest plot of studies estimating the AUCROC (A), O/E ratio,
and O-E difference (B and C) in isolated CABG, isolated valve surgery, and
combined CABG with valve procedures. The first author and reference as
shown in Table 1. ROC, Receiver operating characteristic;CABG, coronary
artery bypass grafting.
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C
DThe performance of the euroSCORE II across the entire
spectrum of risk and different procedures or combination
of surgeries should be better evaluated in populations
with possible suboptimal calibration. High-risk patients
should be more clearly defined and the analysis based
over a greater number of centers and patients than those
involved in this meta-analysis. Moreover, the effects of
performing CABG with a beating-heart technique
(off-pump) in comparison with cardiopulmonary bypass
(on-pump) are not clearly established in terms of risk-
prediction models. A patient-level analysis of prospective
patients undergoing cardiac surgery should be performed
to address both discrimination and calibration of the euro-
SCORE II. A pooled analysis of individual participant
data, evaluating each risk factor of the euroSCORE II,
may allow a deeper assessment of model calibration and
recalibration also adjusting for confounding factors not
included in the score.
CONCLUSIONS
The results from this meta-analysis demonstrate the val-
idity of the euroSCORE II as a risk model for contemporary
practice. The score has good discrimination and is accurate
in predicting operative mortality after cardiac surgery. New
prospective studies directly focusing on the euroSCORE II
should be started to estimate the performance across
different surgical categories, to detect trends over time,
and to evaluate the influence of changes in patient charac-
teristics on risk score accuracy.
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FIGURE E1. Baujat plot of studies estimating the AUC ROC (A), O/E ratio (B), and O-E difference (C). Group A included studies with a retrospective
evaluation of euroSCORE II or that evaluated 30-day mortality as main outcome. Group B included studies that evaluated hospital mortality by including
only patients undergoing operation after the euroSCORE II cohort. The number displayed is the reference. ROC, Receiver operating characteristic.
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